 |
|
Racing against the clock to distribute H1N1 flu vaccine
October 01, 2009Drug companies are sprinting ahead in a race against the clock to deliver millions of doses of vaccine for the H1N1 influenza virus before cooler weather ushers in the 2009-2010 flu season. A two-part cover story in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, focuses on that topic and efforts to develop antiviral drugs for flu infections.
C&EN senior correspondent Ann Thayer cites World Health Organization (WHO) estimates that one-third of the world's population - 2.2 billion people - will be exposed to the H1N1 virus. Although antiviral drugs can help limit the spread of H1N1, a vaccine offers the best means to prevent infection, the article notes.
Although the H1N1 virus just emerged in April, vaccine developers have made an effective vaccine. However, WHO says that only a fraction of the potential supply will be ready for distribution before flu season starts - in October in the Northern Hemisphere. The article describes how at least nine countries have pledged to donate vaccines to help fight the pandemic in developing countries and two vaccine manufacturers have earmarked a portion of their production for developing countries. That generosity will help protect populations that otherwise would not have access to vaccines, the article notes.
American Chemical Society
American Chemical Society
Poll: Many parents, high-priority adults who tried to get H1N1 vaccine unable to get it
A new national poll from Harvard School of Public Health (HSPH) researchers found that a majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so.
Initial Results Show Pregnant Women Mount Strong Immune Response To One Dose of 2009 H1N1 Flu Vaccine
Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.
Most would refuse emergency use H1N1 vaccine or additive
A majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration, according to a University of Pittsburgh Graduate School of Public Health and University of Georgia study.
Early results: In children, 2009 H1N1 influenza vaccine works like seasonal flu vaccine
Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
More H1N1 Flu Vaccine Current Events and H1N1 Flu Vaccine News Articles
 |
Warning Swine Flu Test Subject Keep Back Sign Logo Men's Tee Short Sleeve Size XL White by 99 Volts |
|
Novel H1N1 flu vaccine distribution plans outlined.(INFECTIOUS DISEASES): An article from: Pediatric News by Doug Brunk (Author) This digital document is an article from Pediatric News, published by International Medical News Group on September 1, 2009. The length of the article is 473 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Novel H1N1 flu vaccine distribution plans outlined.(INFECTIOUS DISEASES) Author: Doug Brunk Publication: Pediatric News (Magazine/Journal) Date: September 1, 2009 Publisher: International Medical News Group Volume: 43 Issue: 9 Page: 13(1) Distributed by Gale, a part of Cengage... | |
 |
40 Count Box of N95 Niosh Rated Respirators CDC Recommended for H1N1 Swine Flu Masks by MCS Online Keep yourself safe with this kit of 40 N95 Rated Niosh Respirators! |
 |
60 Minutes - H1N1 (October 18, 2009) Airdate 10/18/09 The H1N1 virus is already setting infection records in this country, and while most people who get this flu can handle it, in some cases, H1N1 can be deadly. Scott Pelley follows the case of 15-year-old Luke Duvall, a high school athlete in intensive care in Little Rock, Arkansas. With staphylococcal pneumonia on top of the H1N1, Luke is on a respirator and fighting for his life. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Sovereign Silver 2 oz Fine Mist Spray by Natural Immunogenics Benefits of Sovereign Silver Bio-Active Silver Hydrosol- To support your immune system for all of its needs, choose Sovereign Silver Bio Active Hydrosol the #1 Selling silver supplement in America.* It has a unique combination of five benefits no other manufacturer can match: 1. Actively Charged (Bio-Active) 2. Easily Absorbed 3. Less Is More 4. Perfectly Safe. 5. 99.999% PURE |
 |
Warning Bird Flu Test Subject Men's Hoodie Sweat Shirt White XXL by 99 Volts |
|
H1N1 flu vaccines enter clinical trials.(NEWS): An article from: Internal Medicine News by Doug Brunk (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on September 1, 2009. The length of the article is 886 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: H1N1 flu vaccines enter clinical trials.(NEWS) Author: Doug Brunk Publication: Internal Medicine News (Magazine/Journal) Date: September 1, 2009 Publisher: International Medical News Group Volume: 42 Issue: 15 Page: 1(2) Distributed by Gale, a part of Cengage... | |
 |
Individual H1N1 Swine Flu Kit Recommended by CDC for Prevention by MCS Online Keep yourself safe this year with the cheapest kit on the market. Kit contains: 1 N95 Niosh Rated Respirator, 1 Bottle of 2 oz Purell, 10 Purell Deep Hand Sanitizing Wipes, 1 Pair of Nitrile Medical Grade Protective Gloves. |
 |
Warning Swine Flu Test Subject Keep Back Sign Logo Women's Tee Shirt Regular Fit Medium White by 99 Volts |
|
Vaccine is just one weapon in the battle against H1N1 flu.(Local Opinion): An article from: The Register-Guard (Eugene, OR) by Unavailable (Author) This digital document is an article from The Register-Guard (Eugene, OR), published by The Register Guard on October 29, 2009. The length of the article is 828 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Vaccine is just one weapon in the battle against H1N1 flu.(Local Opinion) Author: Unavailable Publication: The Register-Guard (Eugene, OR) (Newspaper) Date: October 29, 2009 Publisher: The Register Guard Page: A7 Distributed by Gale, a part of Cengage... |
| © 2009 BrightSurf.com |